home / press / releases

Menu
  • Search all tables

releases: https://www.shaheen.senate.gov/news/press/shaheen-collins-warnock-kennedy-applaud-advancement-of-their-bipartisan-insulin-act-out-of-key-senate-committee

One row per release. Full-text search runs over title + body text.

Data license: MIT · Data source: dwillis/congress-press

This data as json

url title date year month party chamber state member_name bioguide_id domain scraper source date_source text has_text collected_at updated_at
https://www.shaheen.senate.gov/news/press/shaheen-collins-warnock-kennedy-applaud-advancement-of-their-bipartisan-insulin-act-out-of-key-senate-committee Shaheen, Collins, Warnock, Kennedy Applaud Advancement of Their Bipartisan INSULIN Act Out of Key Senate Committee 2026-07-22 2026 2026-07 Democrat Senate NH Jeanne Shaheen S001181 www.shaheen.senate.gov shaheen https://www.shaheen.senate.gov/news/press scraper ***Bipartisan vote out of the HELP Committee is major step toward Senate passage of the legislation*** (Washington, DC) – Today, U.S. Senators Jeanne Shaheen (D-NH), Susan Collins (R-ME), Reverend Raphael Warnock (D-GA) and John Kennedy (R-LA) applauded the advancement of their bipartisan INSULIN Act out of the U.S. Senate Health, Education, Labor and Pensions (HELP) Committee. The bipartisan legislation to cap the monthly out-of-pocket cost of insulin at $35 enjoys strong bipartisan support, with 29 senators backing the bill. “We applaud the advancement of our bipartisan legislation to make insulin more affordable out of the Senate HELP Committee,” said Senators Shaheen, Collins, Warnock and Kennedy. “We are glad that our colleagues on the Committee agreed that action is sorely needed to lower health care costs for American families, including the millions of people who need insulin every day just to survive but struggle to make ends meet. Today's vote brings us another step closer to making insulin affordable and available to those whose lives depend on it and demonstrates the continued bipartisan momentum behind our legislation. We will continue to work every day to get this vital piece of legislation to the Senate floor for a vote.” Polling released last month from the American Diabetes Association found that 40% of respondents who rely on insulin report paying more than $150 per month for insulin, and 76% of respondents across political parties support a $35 limit on cost sharing for insulin. The Improving Needed Safeguards for Users of Lifesaving Insulin Now (INSULIN) Act would cap the monthly out-of-pocket cost of insulin at $35 for Americans on private and employer-sponsored insurance and create a pilot program to provide insulin at the same cost to Americans without insurance. In addition to Shaheen, Collins, Warnock and Kennedy, the legislation is supported by U.S. Senators Jacky Rosen (D-NV), Tommy Tuberville (R-AL), Angus King (I-ME), Lisa Murkowski (R-AK), Mark Kelly (D-AZ), Chuck Grassley (R-IA), Tammy Baldwin (D-WI), Katie Britt (R-AL), Chris Coons (D-DE), Roger Wicker (R-MS), Shelley Moore Capito (R-WV), Tim Kaine (D-VA), Jim Justice (R-WV), Lisa Blunt Rochester (D-DE), Joni Ernst (R-IA), John Hickenlooper (D-CO), Kevin Cramer (R-ND), Angela Alsobrooks (D-MD), Cindy Hyde-Smith (R-MS), Catherine Cortez Masto (D-NV), Jim Banks (R-IN), Cory Booker (D-NJ), Dave McCormick (R-PA), Elissa Slotkin (D-MI) and Mark Warner (D-VA). ### 1 2026-07-23T07:31:02Z 2026-07-23T07:32:26Z
Powered by Datasette · Queries took 1.37ms · Data license: MIT · Data source: dwillis/congress-press